Compounds > acetylcysteine

acetylcysteine and imipenem, anhydrous

acetylcysteine has been researched along with imipenem, anhydrous in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (33.33)29.6817
2010's6 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lombardo, F; Obach, RS; Waters, NJ1
Fukumoto, A; Kim, YP; Matsumoto, A; Omura, S; Shiomi, K; Takahashi, Y; Tomoda, H1
Fukumoto, A; Hanaki, H; Kim, YP; Omura, S; Shiomi, K; Tomoda, H1
Tomoda, H1
Ikeda, H; Koyama, N; Münch, D; Sahl, HG; Schneider, T; Shibagaki, Y; Tokura, Y; Tomoda, H1
Blázquez, J; Bou, G; Cabot, G; Costas, C; Oliver, A; Rodríguez-Beltrán, J; Valencia, EY1
Ikeda, H; Nagamitsu, T; Shin-Ya, K; Tomoda, H1
Di Maggio, T; Docquier, JD; Landini, G; Pallecchi, L; Rossolini, GM; Sergio, F1
Ababneh, MA; Al Demour, S; Alzoubi, KH; Hijjawi, TB; Rababa’h, AM1

Reviews

1 review(s) available for acetylcysteine and imipenem, anhydrous

ArticleYear
[Mode of action of microbial anti-MRSA agents].
    Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2012, Volume: 132, Issue:1

    Topics: Acetylcysteine; Alkyl and Aryl Transferases; Anti-Bacterial Agents; Cross Infection; Diterpenes; Drug Design; Drug Resistance, Bacterial; Drug Synergism; Imipenem; Methicillin-Resistant Staphylococcus aureus; Mycotoxins; Spiro Compounds

2012

Other Studies

8 other study(ies) available for acetylcysteine and imipenem, anhydrous

ArticleYear
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Cyslabdan, a new potentiator of imipenem activity against methicillin-resistant Staphylococcus aureus, produced by Streptomyces sp. K04-0144. I. Taxonomy, fermentation, isolation and structural elucidation.
    The Journal of antibiotics, 2008, Volume: 61, Issue:1

    Topics: Acetylcysteine; Anti-Bacterial Agents; Diterpenes; Drug Synergism; Fermentation; Humans; Imipenem; Magnetic Resonance Spectroscopy; Methicillin Resistance; Microscopy, Electron, Scanning; Molecular Conformation; Molecular Structure; Staphylococcus aureus; Streptomyces

2008
Cyslabdan, a new potentiator of imipenem activity against methicillin-resistant Staphylococcus aureus, produced by Streptomyces sp. K04-0144. II. Biological activities.
    The Journal of antibiotics, 2008, Volume: 61, Issue:1

    Topics: Acetylcysteine; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Diterpenes; Drug Synergism; Humans; Imipenem; Methicillin Resistance; Microbial Sensitivity Tests; Molecular Structure; Staphylococcus aureus; Streptomyces

2008
The nonantibiotic small molecule cyslabdan enhances the potency of β-lactams against MRSA by inhibiting pentaglycine interpeptide bridge synthesis.
    PloS one, 2012, Volume: 7, Issue:11

    Topics: Acetylcysteine; Bacterial Proteins; Boron Compounds; Chromatography, High Pressure Liquid; Diterpenes; DNA Primers; Drug Resistance, Bacterial; Drug Synergism; Imipenem; Japan; Methicillin-Resistant Staphylococcus aureus; Penicillins; Peptides; Peptidoglycan; Spectrophotometry, Ultraviolet; Tandem Mass Spectrometry

2012
N-acetylcysteine selectively antagonizes the activity of imipenem in Pseudomonas aeruginosa by an OprD-mediated mechanism.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:6

    Topics: Acetylcysteine; Acinetobacter baumannii; Anti-Bacterial Agents; Escherichia coli; Gene Expression Regulation, Bacterial; Imipenem; Microbial Sensitivity Tests; Porins; Pseudomonas aeruginosa

2015
Biosynthesis of mercapturic acid derivative of the labdane-type diterpene, cyslabdan that potentiates imipenem activity against methicillin-resistant Staphylococcus aureus: cyslabdan is generated by mycothiol-mediated xenobiotic detoxification.
    Journal of industrial microbiology & biotechnology, 2016, Volume: 43, Issue:2-3

    Topics: Acetylcysteine; Amidohydrolases; Biosynthetic Pathways; Cysteine; Diterpenes; Glycopeptides; Imipenem; Inactivation, Metabolic; Inositol; Methicillin-Resistant Staphylococcus aureus; Multigene Family; Mycelium; Organophosphates; Streptomyces; Xenobiotics

2016
Effect of High N-Acetylcysteine Concentrations on Antibiotic Activity against a Large Collection of Respiratory Pathogens.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:12

    Topics: Acetylcysteine; Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Drug Combinations; Drug Interactions; Enterobacter cloacae; Ertapenem; Escherichia coli; Humans; Imipenem; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Penicillins; Pseudomonas aeruginosa; Respiratory Tract Infections; Staphylococcus aureus; Streptococcus pneumoniae; Streptococcus pyogenes; Thienamycins

2016
The Nephroprotective Effect of N-Acetyl-L-Cysteine and Atorvastatin against Imipenem induced Nephrotoxicity.
    Current molecular pharmacology, 2018, Volume: 11, Issue:2

    Topics: Acetylcysteine; Animals; Antioxidants; Atorvastatin; Blood Urea Nitrogen; Creatinine; Glomerular Filtration Rate; Glycosuria; Imipenem; Kidney; Kidney Diseases; Male; Protective Agents; Proteinuria; Rats, Sprague-Dawley; Thiobarbituric Acid Reactive Substances; Urea

2018